AbbVie Inc (NYSE:ABBV) is a research-based pharmaceutical company, spun off from Abbott Laboratories in 2013. It has a market cap of $119.9 billion, a PE ratio of 18.3 and a dividend yield of 3.4 per cent. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether AbbVie Inc is hot or not.